These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24768611)

  • 21. Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients.
    Faggioni M; Hwang HS; van der Werf C; Nederend I; Kannankeril PJ; Wilde AA; Knollmann BC
    Circ Res; 2013 Feb; 112(4):689-97. PubMed ID: 23295832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin.
    Galimberti ES; Knollmann BC
    J Mol Cell Cardiol; 2011 Nov; 51(5):760-8. PubMed ID: 21798265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.
    Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S
    Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.
    Kalyanasundaram A; Viatchenko-Karpinski S; Belevych AE; Lacombe VA; Hwang HS; Knollmann BC; Gyorke S; Periasamy M
    Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H253-61. PubMed ID: 21984545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calsequestrin 2 and arrhythmias.
    Faggioni M; Knollmann BC
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1250-60. PubMed ID: 22198169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ablation of HRC alleviates cardiac arrhythmia and improves abnormal Ca handling in CASQ2 knockout mice prone to CPVT.
    Liu B; Ho HT; Brunello L; Unudurthi SD; Lou Q; Belevych AE; Qian L; Kim DH; Cho C; Janssen PM; Hund TJ; Knollmann BC; Kranias EG; Györke S
    Cardiovasc Res; 2015 Nov; 108(2):299-311. PubMed ID: 26410369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
    Chopra N; Kannankeril PJ; Yang T; Hlaing T; Holinstat I; Ettensohn K; Pfeifer K; Akin B; Jones LR; Franzini-Armstrong C; Knollmann BC
    Circ Res; 2007 Sep; 101(6):617-26. PubMed ID: 17656677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral gene transfer rescues arrhythmogenic phenotype and ultrastructural abnormalities in adult calsequestrin-null mice with inherited arrhythmias.
    Denegri M; Avelino-Cruz JE; Boncompagni S; De Simone SA; Auricchio A; Villani L; Volpe P; Protasi F; Napolitano C; Priori SG
    Circ Res; 2012 Mar; 110(5):663-8. PubMed ID: 22298808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia.
    Lodola F; Morone D; Denegri M; Bongianino R; Nakahama H; Rutigliano L; Gosetti R; Rizzo G; Vollero A; Buonocore M; Napolitano C; Condorelli G; Priori SG; Di Pasquale E
    Cell Death Dis; 2016 Oct; 7(10):e2393. PubMed ID: 27711080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.
    Novak A; Barad L; Lorber A; Gherghiceanu M; Reiter I; Eisen B; Eldor L; Itskovitz-Eldor J; Eldar M; Arad M; Binah O
    J Cell Mol Med; 2015 Aug; 19(8):2006-18. PubMed ID: 26153920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pacing Dynamics Determines the Arrhythmogenic Mechanism of the CPVT2-Causing CASQ2
    Paudel R; Jafri MS; Ullah A
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Purkinje-myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT.
    Blackwell DJ; Faggioni M; Wleklinski MJ; Gomez-Hurtado N; Venkataraman R; Gibbs CE; Baudenbacher FJ; Gong S; Fishman GI; Boyle PM; Pfeifer K; Knollmann BC
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-natal heart adaptation in a knock-in mouse model of calsequestrin 2-linked recessive catecholaminergic polymorphic ventricular tachycardia.
    Valle G; Boncompagni S; Sacchetto R; Protasi F; Volpe P
    Exp Cell Res; 2014 Feb; 321(2):178-89. PubMed ID: 24370574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.
    Faggioni M; Kryshtal DO; Knollmann BC
    Pediatr Cardiol; 2012 Aug; 33(6):959-67. PubMed ID: 22421959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditional ablation and conditional rescue models for Casq2 elucidate the role of development and of cell-type specific expression of Casq2 in the CPVT2 phenotype.
    Flores DJ; Duong T; Brandenberger LO; Mitra A; Shirali A; Johnson JC; Springer D; Noguchi A; Yu ZX; Ebert SN; Ludwig A; Knollmann BC; Levin MD; Pfeifer K
    Hum Mol Genet; 2018 May; 27(9):1533-1544. PubMed ID: 29452352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interplay between Triadin and Calsequestrin in the Pathogenesis of CPVT in the Mouse.
    Cacheux M; Fauconnier J; Thireau J; Osseni A; Brocard J; Roux-Buisson N; Brocard J; Fauré J; Lacampagne A; Marty I
    Mol Ther; 2020 Jan; 28(1):171-179. PubMed ID: 31607542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
    Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
    Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes.
    Savio-Galimberti E; Knollmann BC
    PLoS One; 2015; 10(6):e0131179. PubMed ID: 26121139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond.
    Katz G; Arad M; Eldar M
    Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.
    Chen B; Guo A; Gao Z; Wei S; Xie YP; Chen SR; Anderson ME; Song LS
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):841-9. PubMed ID: 22722659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.